
Sign up to save your podcasts
Or
Moderator: Barbara Tettenborn (St. Gallen, Switzerland)
Guest: Thomas Meinel (Bern, Switzerland)
Thomas Meinel, a clinician scientist at the Burn Stroke Research Center in Switzerland, is hosted by Barbara Tettenborn as they discuss covert cerebrovascular disease. His research, particularly on strokes in patients on anticoagulation, is explored, highlighting the frequency and clinical implications of covert cerebrovascular lesions. Meinel emphasizes the current lack of clear evidence for managing these conditions. He also shares insights into ongoing studies that aim to connect epidemiological knowledge with clinical practices, encouraging neurologists to recognize and address covert cerebrovascular disease in patient care.
Moderator: Barbara Tettenborn (St. Gallen, Switzerland)
Guest: Thomas Meinel (Bern, Switzerland)
Thomas Meinel, a clinician scientist at the Burn Stroke Research Center in Switzerland, is hosted by Barbara Tettenborn as they discuss covert cerebrovascular disease. His research, particularly on strokes in patients on anticoagulation, is explored, highlighting the frequency and clinical implications of covert cerebrovascular lesions. Meinel emphasizes the current lack of clear evidence for managing these conditions. He also shares insights into ongoing studies that aim to connect epidemiological knowledge with clinical practices, encouraging neurologists to recognize and address covert cerebrovascular disease in patient care.
134 Listeners
288 Listeners
27 Listeners
318 Listeners
10 Listeners
47 Listeners
498 Listeners
12 Listeners
22 Listeners
131 Listeners
9 Listeners
10 Listeners
6 Listeners
8 Listeners
78 Listeners